Perfluorinated chemicals (PFOA) can, by interacting with highly brominated diphenyl ethers (PBDE 209) during a defined period of neonatal brain development, exacerbate neurobehavioural defects

Neurotoxicol Teratol. 2023 Mar-Apr:96:107150. doi: 10.1016/j.ntt.2022.107150. Epub 2022 Dec 27.

Abstract

Perfluorinated compounds (PFCs) and polybrominated diphenyl ethers (PBDEs) are ubiquitous persistent environmental compounds, present in humans and at higher levels in infants/children than in adults. This study shows that co-exposure to pentadecafluorooctanoic acid (PFOA) and 2,2',3,3',4,4',5,5',6,6'-decaBDE (PBDE 209) can significantly exacerbate developmental neurobehavioural defects. Neonatal male NMRI mice, 3 and 10 days old, were exposed perorally to PBDE 209 (1.4 or 8.0 μmol/kg bw), PFOA (1.4 or 14 μmol/kg bw), co-exposed to PBDE 209 and PFOA (at the given doses), or a vehicle (20% fat emulsion) and observed for spontaneous behaviour in a novel home environment when 2 and 4 months old. The behavioural defects observed included hyperactivity and reduced habituation indicating cognitive defects. This interaction appears most likely dependent on the presence of PBDE 209 and/or its metabolites together with PFOA, during a defined critical period of neonatal brain development, corresponding to the perinatal and newborn period in humans.

Keywords: Behaviour; Brominated flame retardants; Co-exposure; Developmental neurotoxicity; Perfluorinated compounds; Polybrominated diphenyl ethers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Brain
  • Child
  • Female
  • Flame Retardants*
  • Halogenated Diphenyl Ethers / toxicity
  • Humans
  • Infant
  • Male
  • Mice
  • Polybrominated Biphenyls*
  • Pregnancy

Substances

  • decabromobiphenyl ether
  • Halogenated Diphenyl Ethers
  • perfluorooctanoic acid
  • Polybrominated Biphenyls
  • Flame Retardants